α-blocker Market Report

Global and Region α-blocker Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：196
  • REPORT CODE：GMM920446
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of α-blocker market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of α-blockermarket, defines the market attractiveness level of α-blocker market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of α-blocker industry, describes the types of α-blocker market, the applications of major players and the market size, and deeply analyzes the current situation of the global α-blocker market and the development prospects and opportunities of α-blocker industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global α-blocker market in Chapter 13.

    By Player:

    • Jhonson and Johnson

    • Pfizer

    • Astra Zeneca

    • GSK

    • Merck

    • Eli Lilly

    • Novartis

    • Teva Pharmaceutical

    • Sanofi

    • Bayer

    • Bristol-Myers Squibb

    By Type:

    • Non-selective Antagonists

    • Selective Antagonists

    By End-User:

    • Hypertension

    • Raynaud's Disease

    • Erectile Dysfunction

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 α-blocker Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 α-blocker Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 α-blocker Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 α-blocker Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise α-blocker Market Analysis and Outlook to 2022

    • 7.1 Global α-blocker Consumption (2017-2022)

    • 7.2 United States α-blocker Consumption (2017-2022)

    • 7.3 Europe α-blocker Consumption (2017-2022)

    • 7.4 China α-blocker Consumption (2017-2022)

    • 7.5 Japan α-blocker Consumption (2017-2022)

    • 7.6 India α-blocker Consumption (2017-2022)

    • 7.7 South Korea α-blocker Consumption (2017-2022)

    8 Region and Country-wise α-blocker Market Analysis and Outlook to 2028

    • 8.1 Global α-blocker Consumption Forecast (2022-2028)

    • 8.2 United States α-blocker Consumption Forecast (2022-2028)

    • 8.3 Europe α-blocker Consumption Forecast (2022-2028)

    • 8.4 China α-blocker Consumption Forecast (2022-2028)

    • 8.5 Japan α-blocker Consumption Forecast (2022-2028)

    • 8.6 India α-blocker Consumption Forecast (2022-2028)

    • 8.7 South Korea α-blocker Consumption Forecast (2022-2028)

    9 Global α-blocker Market Outlook by Types and Applications to 2022

    • 9.1 Global α-blocker Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Non-selective Antagonists Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Selective Antagonists Consumption and Growth Rate (2017-2022)

    • 9.2 Global α-blocker Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hypertension Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Raynaud's Disease Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Erectile Dysfunction Consumption and Growth Rate (2017-2022)

    10 Global α-blocker Market Outlook by Types and Applications to 2028

    • 10.1 Global α-blocker Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Non-selective Antagonists Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Selective Antagonists Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global α-blocker Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hypertension Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Raynaud's Disease Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Erectile Dysfunction Consumption Forecast and Growth Rate (2022-2028)

    11 Global α-blocker Import and Export Analysis (Top 5 Countries)

    • 11.1 Global α-blocker Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global α-blocker Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 α-blocker Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global α-blocker Market Competitive Analysis

    • 14.1 Jhonson and Johnson

      • 14.1.1 Jhonson and Johnson Company Details

      • 14.1.2 Jhonson and Johnson α-blocker Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Jhonson and Johnson α-blocker Product and Service

    • 14.2 Pfizer

      • 14.2.1 Pfizer Company Details

      • 14.2.2 Pfizer α-blocker Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Pfizer α-blocker Product and Service

    • 14.3 Astra Zeneca

      • 14.3.1 Astra Zeneca Company Details

      • 14.3.2 Astra Zeneca α-blocker Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Astra Zeneca α-blocker Product and Service

    • 14.4 GSK

      • 14.4.1 GSK Company Details

      • 14.4.2 GSK α-blocker Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 GSK α-blocker Product and Service

    • 14.5 Merck

      • 14.5.1 Merck Company Details

      • 14.5.2 Merck α-blocker Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Merck α-blocker Product and Service

    • 14.6 Eli Lilly

      • 14.6.1 Eli Lilly Company Details

      • 14.6.2 Eli Lilly α-blocker Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Eli Lilly α-blocker Product and Service

    • 14.7 Novartis

      • 14.7.1 Novartis Company Details

      • 14.7.2 Novartis α-blocker Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Novartis α-blocker Product and Service

    • 14.8 Teva Pharmaceutical

      • 14.8.1 Teva Pharmaceutical Company Details

      • 14.8.2 Teva Pharmaceutical α-blocker Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Teva Pharmaceutical α-blocker Product and Service

    • 14.9 Sanofi

      • 14.9.1 Sanofi Company Details

      • 14.9.2 Sanofi α-blocker Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Sanofi α-blocker Product and Service

    • 14.10 Bayer

      • 14.10.1 Bayer Company Details

      • 14.10.2 Bayer α-blocker Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Bayer α-blocker Product and Service

    • 14.11 Bristol-Myers Squibb

      • 14.11.1 Bristol-Myers Squibb Company Details

      • 14.11.2 Bristol-Myers Squibb α-blocker Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Bristol-Myers Squibb α-blocker Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of α-blocker

    • Figure α-blocker Picture

    • Table Global α-blocker Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global α-blocker Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global α-blocker Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global α-blocker Consumption by Country (2017-2022)

    • Figure United States α-blocker Consumption and Growth Rate (2017-2022)

    • Table Europe α-blocker Consumption and Growth Rate (2017-2022)

    • Figure China α-blocker Consumption and Growth Rate (2017-2022)

    • Figure Japan α-blocker Consumption and Growth Rate (2017-2022)

    • Figure India α-blocker Consumption and Growth Rate (2017-2022)

    • Figure South Korea α-blocker Consumption and Growth Rate (2017-2022)

    • Figure Global α-blocker Consumption Forecast by Country (2022-2028)

    • Figure United States α-blocker Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe α-blocker Consumption Forecast and Growth Rate (2022-2028)

    • Figure China α-blocker Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan α-blocker Consumption Forecast and Growth Rate (2022-2028)

    • Figure India α-blocker Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea α-blocker Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Non-selective Antagonists Consumption and Growth Rate (2017-2022)

    • Figure Global Selective Antagonists Consumption and Growth Rate (2017-2022)

    • Figure Global Hypertension Consumption and Growth Rate (2017-2022)

    • Figure Global Raynaud's Disease Consumption and Growth Rate (2017-2022)

    • Figure Global Erectile Dysfunction Consumption and Growth Rate (2017-2022)

    • Figure Global Non-selective Antagonists Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Selective Antagonists Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hypertension Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Raynaud's Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Erectile Dysfunction Consumption Forecast and Growth Rate (2022-2028)

    • Table Global α-blocker Import by Region (Top 5 Countries) (2017-2028)

    • Table Global α-blocker Export by Region (Top 5 Countries) (2017-2028)

    • Table Jhonson and Johnson (Foundation Year, Company Profile and etc.)

    • Table Jhonson and Johnson α-blocker Sales, Price, Value and Gross Profit (2017-2022)

    • Table Jhonson and Johnson α-blocker Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer α-blocker Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer α-blocker Product and Service

    • Table Astra Zeneca (Foundation Year, Company Profile and etc.)

    • Table Astra Zeneca α-blocker Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astra Zeneca α-blocker Product and Service

    • Table GSK (Foundation Year, Company Profile and etc.)

    • Table GSK α-blocker Sales, Price, Value and Gross Profit (2017-2022)

    • Table GSK α-blocker Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck α-blocker Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck α-blocker Product and Service

    • Table Eli Lilly (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly α-blocker Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly α-blocker Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis α-blocker Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis α-blocker Product and Service

    • Table Teva Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Teva Pharmaceutical α-blocker Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharmaceutical α-blocker Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi α-blocker Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi α-blocker Product and Service

    • Table Bayer (Foundation Year, Company Profile and etc.)

    • Table Bayer α-blocker Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer α-blocker Product and Service

    • Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Squibb α-blocker Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb α-blocker Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US